Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dingell food safety bill

This article was originally published in The Tan Sheet

Executive Summary

House Energy and Commerce Chairman John Dingell's, D-Mich., draft legislation on food safety would require FDA to collect user fees on food imported into the U.S., with the revenue used to support import inspections, lab testing on import samples and research on testing techniques for intentionally adulterated food imports. The bill, which had not been filed or assigned a number as of Aug. 10, would also prevent FDA from closing or consolidating its 13 FDA field laboratories, Dingell says in an Aug. 3 release. "Without regular inspections and analysis there is little incentive for food producers and importers to ensure that our food supply is free from harmful and sometimes fatal contaminants," he says. The bill would grant FDA authority to issue mandatory recalls; require country of origin labeling; limit the number of ports of entry for food items; halt imports of certain products until a foreign facility can demonstrate that significant steps have been taken to rectify an identified problem; and increase civil monetary penalties for manufacturers or importers that violate the Food, Drug and Cosmetic Act. Dingell has been a frequent critic of FDA's food safety oversight and has said he would introduce legislation to bring about sweeping changes (1"The Tan Sheet" July 9, 2007, p. 9)...

You may also be interested in...

Counterfeit Drugs, Food Safety Are Expected Focus Of New FDA Bill In House

Tightened security for counterfeit drugs and food imports are slated to be addressed in another bill aimed at boosting FDA's oversight powers, Energy and Commerce Committee Chairman John Dingell, D-Mich., said during markup of drug safety legislation

Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts

Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.

Back With A Bang: ‘Brexit Bill’ For UK’s Medical Devices Due For 2nd Reading On 2 March

Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts